Kemistar board meet Aug 13, 2026 for Q1 results

What the company has told the market

Kemistar Corporation Ltd (BSE: 531163; ISIN: INE971L01029), an agro chemicals and pesticides player, has scheduled a board meeting for Thursday, August 13, 2026. The stated purpose is to consider and approve unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company also plans to discuss quarterly compliance filings with BSE Limited.

For investors, the date matters because it signals when the June-quarter numbers will be formally reviewed and placed on record. Such board meetings typically precede the filing of results on the exchange, and can bring clarity on recent operating performance.

Trading window closure: key compliance detail

Kemistar has disclosed that the trading window for the company’s securities has been closed since July 1, 2026. It will remain closed until August 15, 2026. The restriction applies to directors, key managerial personnel, designated employees, and their immediate relatives.

Trading window closures are part of standard compliance practices around results periods, aimed at restricting trading by insiders when unpublished price sensitive information may exist.

Where the stock was trading

The share price of KEMISTAR as on August 10, 2026 was reported at ₹49.69. The provided data also shows other on-screen prices at different times, including ₹53.98 (+7.96%) during market hours and ₹48.50 (+0.02%) in another quote snapshot.

These separate price points appear to reflect different timestamps or sources within the same compilation, rather than a single closing price series. Investors typically track the exchange close price around the results date to judge immediate market reaction.

FY26 audited results: what was approved on May 30, 2026

Kemistar’s latest audited-results board meeting took place on May 30, 2026, with the purpose listed as “Audited Results.” In the board meeting outcome shared in the provided text, the company said its board approved Q4 FY26 and full FY26 audited financial results.

Alongside the results, the board appointed Ms. Aesha Mashru as Internal Auditor for FY27, as per the disclosure included in the source text.

Consolidated Q4 FY26 performance: sales, profit, EBITDA

The disclosed consolidated quarterly numbers for the March 2026 quarter (Q4 FY26) indicated year-on-year growth in both revenue and profit.

• Net Sales at ₹10.05 crore in March 2026, up 43.06% from ₹7.03 crore in March 2025.
• Quarterly Net Profit at ₹0.42 crore in March 2026, up 48.49% from ₹0.29 crore in March 2025.
• EBITDA at ₹0.55 crore in March 2026, up 3.77% from ₹0.53 crore in March 2025.
• EPS increased to ₹0.39 in March 2026 from ₹0.27 in March 2025.

The same dataset also states that Kemistar shares closed at 60.35 on June 02, 2026 (BSE) and delivered -25.49% returns over the last 6 months and -20.79% over the last 12 months.

Snapshot of the consolidated quarterly line items (as provided)

The table below reproduces the key consolidated quarterly line items included in the provided text for Mar’26, Dec’25, and Mar’25.

Note: Several expense lines were shown as “—” in the source extract.

Half-yearly profitability cues: expenses and profit lines

A half-yearly table in the provided data shows selected line items in ₹ crore across Mar’26, Sep’25, Mar’25, Sep’24, and Mar’24. While the table extract is partial, it still provides a view of expenses and profit over multiple periods.

• Total expenses: 1.77 (Mar’26), 1.33 (Sep’25), 1.45 (Mar’25), 1.37 (Sep’24), 1.86 (Mar’24)
• Operating profit: 0.04 (Mar’26), 0.12 (Sep’25), 0.04 (Mar’25), 0.19 (Sep’24), 0.20 (Mar’24)
• EBITDA: 0.16 (Mar’26), 0.14 (Sep’25), 0.07 (Mar’25), 0.22 (Sep’24), 0.21 (Mar’24)
• EBIT: 0.12 (Mar’26), 0.10 (Sep’25), 0.03 (Mar’25), 0.17 (Sep’24), 0.20 (Mar’24)
• Profit and loss for the year / Reported PAT: 0.06 (Mar’26), 0.09 (Sep’25), -0.04 (Mar’25), 0.16 (Sep’24), 0.14 (Mar’24)

The extract also showed EPS (Rs.) as NaN across these half-yearly columns.

Dividend and corporate filings mentioned

The provided text states that Kemistar Corporation Ltd. declared a dividend of ₹0.30 on September 23, 2025.

Separately, the data includes a reference to a “Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on June 30, 2026,” indicating routine depository compliance documentation.

Key dates at a glance

Market impact: what to watch around August 13

The immediate market focus will be the unaudited standalone and consolidated numbers for the quarter ended June 30, 2026 and any related filings the company makes with BSE. With the trading window scheduled to reopen after August 15, the timeline indicates the company is following a standard results and compliance cadence.

Investors may also contextualise the June-quarter outcome against the FY26 March-quarter consolidated figures that showed sales of ₹10.05 crore and net profit of ₹0.42 crore, both higher year-on-year. At the same time, the same disclosure set noted negative stock returns over 6 and 12 months from the June 02, 2026 close, underlining that price performance and operating performance may not always move in tandem.

Why this matters for the agro chemicals segment

Kemistar’s sector classification in the provided data is Pesticides and Agro Chemicals. For companies in this space, quarterly disclosures can provide updated information on demand conditions, cost lines such as traded goods and employee cost, and profitability measures like EBITDA and PAT.

Because the August 13 board meeting covers both standalone and consolidated results, it can help investors compare performance across the two reporting bases, once the filings are released.

Conclusion

Kemistar Corporation’s August 13, 2026 board meeting sets a clear date for the review and approval of June-quarter unaudited financial results and related BSE compliance filings. The company has also indicated its trading window will stay closed until August 15, 2026. The next formal update is expected through the outcome and financial result filings following the board meeting.